Houria Debarri

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO.

Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO.

Journal: Leukemia

Published: July 25, 2022

Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohort.

Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohort.

Journal: International journal of antimicrobial agents

Published: October 17, 2018

IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia.

IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 26, 2015

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association.

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association.

Journal: Oncotarget

Published: June 04, 2015

Bendamustine is effective in T-cell prolymphocytic leukaemia.

Bendamustine is effective in T-cell prolymphocytic leukaemia.

Journal: British journal of haematology

Published: October 16, 2014

Mixed phenotype acute leukaemia with Burkitt-like cells and positive peroxidase cytochemistry.

Mixed phenotype acute leukaemia with Burkitt-like cells and positive peroxidase cytochemistry.

Journal: British journal of haematology

Published: August 13, 2013

Brentuximab vedotin: new treatment for CD30+ lymphomas

Brentuximab vedotin: new treatment for CD30+ lymphomas

Journal: Bulletin du cancer

Published: July 09, 2013

Efficacy and safety profile of long-term exposure to lenalidomide in patients with recurrent multiple myeloma.

Efficacy and safety profile of long-term exposure to lenalidomide in patients with recurrent multiple myeloma.

Journal: Cancer

Published: March 30, 2013

Prognostic value of PINI index in patients with multiple myeloma.

Prognostic value of PINI index in patients with multiple myeloma.

Journal: European journal of haematology

Published: December 01, 2011

Showing 1-9 of 9

Last Updated: 09/26/2026